Théo de Witte

17.0k citations

137 papers · 7.0k indexed · 3 hit papers · h-index 40

Impact in

Hematology top 0.1%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Chronic Myeloid Leukemia Treatments
Genetics top 0.5%
- Myeloproliferative Neoplasms: Diagnosis and Treatment

Papers in

Hematology 104
- Acute Myeloid Leukemia Research 78
- Hematopoietic Stem Cell Transplantation 49
- Chronic Myeloid Leukemia Treatments 19
- Multiple Myeloma Research and Treatments 12
Genetics 28
- Hemoglobinopathies and Related Disorders 12
- Myeloproliferative Neoplasms: Diagnosis and Treatment 11

Co-authors: Hein Putter Ronald B. Geskus Per Kragh Andersen Joop H. Jansen Bert A. van der Reijden Marion Massop Saskia Langemeijer Ruth Knops
Journals: Blood (47 papers)British Journal of Haematology (13 papers)Journal of Clinical Oncology (7 papers)Biology of Blood and Marrow Transplantation (6 papers)Annals of Hematology (6 papers)
Partner nations: Netherlands Germany Italy

In The Last Decade

Théo de Witte

133 papers receiving 6.9k citations

Hit Papers

align trajectories log scale

Competing risks in epidemiology: possibilities and pitfalls 2012 · 689 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2012 International Journal of Epidemiology
2010 Nature Genetics
2009 Nature Genetics

Peers

Countries citing papers authored by Théo de Witte

Since Specialization

Citations

This map shows the geographic impact of Théo de Witte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Théo de Witte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Théo de Witte more than expected).

Fields of papers citing papers by Théo de Witte

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Théo de Witte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Théo de Witte. The network helps show where Théo de Witte may publish in the future.

Co-authors

The 25 scholars most cited alongside Théo de Witte, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Théo de Witte Line = papers co-authored together Théo de Witte links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Management of adult patients with CMML undergoing allo-HCT: recommendations from the EBMT PH&G Committee Blood ·Francesco Onida, Nico Gagelmann, Yves Chalandon, Guido Kobbe, Marie Robin, Argiris Symeonidis, Théo de Witte, Raphaël Itzykson, Madlen Jentzsch, Uwe Platzbecker, Valeria Santini, Guillermo Sanz, Christof Scheid, Éric Solary, Peter Valent, Raffaela Greco, Isabel Sánchez‐Ortega, Ibrahim Yakoub‐Agha, Lisa Pleyer	2024	8
2	Core set of patient-reported outcomes for myelodysplastic syndromes: an EUMDS Delphi study involving patients and hematologists Blood Advances ·Igor Stojkov, Annette Conrads‐Frank, Ursula Rochau, Karin A. Koinig, Marjan Arvandi, Sibylle Puntscher, Corine van Marrewijk, Pierre Fenaux, Argiris Symeonidis, Fatiha Chermat, Hege Garelius, David Bowen, Moshe Mittelman, Elvira Mora, Théo de Witte, Fabio Efficace, Uwe Siebert, Reinhard Stauder	2021	4
3	Benign ethnic neutropenia: an analysis of prevalence, timing and identification accuracy in two large inner-city NHS hospitals BMC Psychiatry ·Ebenezer Oloyede, Olubanké Dzahini, Nigel Barnes, Aleksandar Mijović, Shreyans Gandhi, Sara Stuart‐Smith, Théo de Witte, David Taylor, Eromona Whiskey	2021	15
4	A phase I clinical trial to study the safety of treatment with tipifarnib combined with bortezomib in patients with advanced stages of myelodysplastic syndrome and oligoblastic acute myeloid leukemia Leukemia Research ·Petra Muus, Saskia Langemeijer, Sandra van Bijnen, Nicole M. A. Blijlevens, Théo de Witte	2021	6
5	Diagnosis and Treatment of Chronic Myelomonocytic Leukemias in Adults HemaSphere ·Raphaël Itzykson, Pierre Fenaux, David Bowen, Nicholas C.P. Cross, Jörge E. Cortes, Théo de Witte, Ulrich Germing, Francesco Onida, Eric Padron, Uwe Platzbecker, Valeria Santini, Guillermo Sanz, Éric Solary, Arjan van de Loosdrecht, Luca Malcovati	2018	65
6	Elevated serum ferritin is not specific for hemophagocytic lymphohistiocytosis Annals of Hematology ·Zaher K. Otrock, Karl Hock, Sarah B. Riley, Théo de Witte, Charles S. Eby, Mitchell G. Scott	2017	48
7	Apoptosis-Related Gene Expression Profiling in Hematopoietic Cell Fractions of MDS Patients PLoS ONE ·Saskia Langemeijer, Niccolò Mariani, Ruth Knops, Christian Gilissen, Rob Woestenenk, Théo de Witte, Gerwin Huls, Bert A. van der Reijden, Joop H. Jansen	2016	15
8	Decitabine versus best supportive care in older patients with refractory anemia with excess blasts in transformation (RAEBt) - results of a subgroup analysis of the randomized phase III study 06011 of the EORTC Leukemia Cooperative Group and German MDS Study Group (GMDSSG) Annals of Hematology ·Heiko Becker, Stefan Suciu, Björn Rüter, Uwe Platzbecker, Aristoteles Giagounidis, Dominik Selleslag, Boris Labar, Ulrich Germing, Helmut R. Salih, Petra Muus, Karl-Heinz Pflüger, Anne Hagemeijer, Hans‐Eckart Schaefer, Valeria Fiaccadori, Frédéric Baron, Arnold Ganser, Carlo Aul, Théo de Witte, Pierre W. Wijermans, Michael Lübbert	2015	16
9	Competing risks in epidemiology: possibilities and pitfalls International Journal of Epidemiology ·Per Kragh Andersen, Ronald B. Geskus, Théo de Witte, Hein Putter Hit paper breakdown →	2012	689
10	Tandem Autologous/Reduced-Intensity Conditioning Allogeneic Stem-Cell Transplantation Versus Autologous Transplantation in Myeloma: Long-Term Follow-Up Journal of Clinical Oncology ·Bo Björkstrand, Simona Iacobelli, Ute Hegenbart, Astrid Gruber, Hildegard Greinix, Liisa Volin, Franco Narni, Pellegrino Musto, Meral Beksaç, Alberto Bosi, Giuseppe Milone, Paolo Corradini, Hartmut Goldschmidt, Théo de Witte, Curly Morris, Dietger Niederwieser, Gösta Gahrton	2011	118
11	T cells expressing the activating NK-cell receptors KIR2DS4, NKG2C and NKG2D are elevated in paroxysmal nocturnal hemoglobinuria and cytotoxic toward hematopoietic progenitor cell lines Experimental Hematology ·Sandra T. A. van Bijnen, Marian Withaar, Frank Preijers, Arnold van der Meer, Théo de Witte, Petra Muus, Harry Dolstra	2011	12
12	Unrelated stem cell transplantation after reduced intensity conditioning for patients with multiple myeloma relapsing after autologous transplantation British Journal of Haematology ·Nicolaus Kröger, Avichai Shimoni, Georgia Schilling, Rainer Schwerdtfeger, Martin Bornhäuser, Arnon Nagler, Axel R. Zander, Marion Heinzelmann, Ronald Brand, Gösta Gahrton, Curly Morris, Dietger Niederwieser, Théo de Witte	2009	42
13	Refinement of molecular approaches to improve the chance of identification of hematopoietic-restricted minor histocompatibility antigens Journal of Immunological Methods ·B. de Rijke, Agnes van Horssen-Zoetbrood, Sharon Veenbergen, Hanny Fredrix, Théo de Witte, E. van de Wiel-van Kemenade, Harry Dolstra	2007	1
14	Bone marrow mononuclear cells of MDS patients are characterized by in vitro proliferation and increased apoptosis independently of stromal interactions Leukemia Research ·Lambert F. R. Span, E. Rutten, Anita Gemmink, J.B.M. Boezeman, Reinier Raymakers, Théo de Witte	2007	6
15	Programmed cell death is an intrinsic feature of MDS progenitors, predominantly found in the cluster-forming cells Experimental Hematology ·Lambert F. R. Span, G. Vierwinden, Arie Pennings, J.B.M. Boezeman, Reinier Raymakers, Théo de Witte	2005	13
16	Systematic screening at diagnosis of −5/del(5)(q31), −7, or chromosome 8 aneuploidy by interphase fluorescence in situ hybridization in 110 acute myelocytic leukemia and high-risk myelodysplastic syndrome patients: concordances and discrepancies with conventional cytogenetics Cancer Genetics and Cytogenetics ·Valérie Beyer, Chantal Castagné, Dominique Mühlematter, V. Parlier, J Gmür, U Hess, Tibor Kovacsovics, Sandrine Meyer‐Monard, André Tichelli, Andreas Tobler, E Jacky, Urs Schanz, Mario Bargetzi, Anne Hagemeijer, Théo de Witte, Guy van Melle, Martine Jotterand	2004	31
17	Bcl-2 prevents loss of mitochondria in CCCP-induced apoptosis Experimental Cell Research ·Aniek O. de Graaf, Lambert P. van den Heuvel, Henry Dijkman, Ronney A. De Abreu, Kim U. Birkenkamp, Théo de Witte, Bert A. van der Reijden, Jan Smeıtınk, Joop H. Jansen	2004	83
18	Abnormal WT1 expression in the CD34‐negative compartment in myelodysplastic bone marrow British Journal of Haematology ·Jeroen P. van Dijk, Gertrudis H. J. N. Knops, L. T. F. Van De Locht, Aswin Menke, Joop H. Jansen, E. J. B. M. Mensink, Reinier Raymakers, Théo de Witte	2002	28
19	Allogeneic stem cell transplantation of adult chronic myelomonocytic leukaemia. A report on behalf of the Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT) British Journal of Haematology ·Nicolaus Kröger, Tatjana Zabelina, P. Guardiola, Volker Runde, Jorge Sierra, Anja van Biezen, Dietger Niederwieser, Axel R. Zander, Théo de Witte	2002	70
20	Bone marrow transplantation for acute myeloblastic leukaemia: an EBMT Leukaemia Working Party prospective analysis from HLA‐typing British Journal of Haematology ·Per Ljungman, Théo de Witte, Leo Verdonck, Gösta Gahrton, F Freyçon, P Gravett, Shaun R. McCann, H. G. Morgenstern, J Nikoskelainen, R Powles, Steven J. Proctor, Liisa Volin, F. E. Zwaan, Aloïs Gratwohl	1993	33

About Théo de Witte

Théo de Witte is a scholar working on Hematology, Genetics, Public Health, Environmental and Occupational Health, Immunology and Transplantation, having authored 137 papers that have together received 7.0k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (78 papers), Hematopoietic Stem Cell Transplantation (49 papers), Acute Lymphoblastic Leukemia research (39 papers), Chronic Myeloid Leukemia Treatments (19 papers), Multiple Myeloma Research and Treatments (12 papers), Hemoglobinopathies and Related Disorders (12 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (11 papers) and Immunotherapy and Immune Responses (9 papers). The work is most often cited by research in Hematology (3.7k citations), Genetics (1.5k citations), Immunology (1.2k citations), Oncology (1.1k citations) and Molecular Biology (2.7k citations). Théo de Witte has collaborated with scholars based in Netherlands, Germany and Italy. Frequent co-authors include Hein Putter, Ronald B. Geskus, Per Kragh Andersen, Joop H. Jansen, Bert A. van der Reijden, Marion Massop, Saskia Langemeijer, Ruth Knops, Peter Vandenberghe and Roland P. Kuiper. Their work appears in journals such as Blood, British Journal of Haematology, Journal of Clinical Oncology, Biology of Blood and Marrow Transplantation and Annals of Hematology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact